Elevated serum BAFF in patients with ocular cicatricial pemphigoid

Reliability of Conjunctival Biopsy for Diagnosis of Ocular Mucous Membrane Pemphigoid: Redetermination of the Standard for Diagnosis and Outcomes of Previously Biopsy-Negative Patients

(2020) Stephen D. Anesi et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)

(2020) Tamara Möckel et al.   AUTOIMMUNITY REVIEWS

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol

(2019) Y K Onno Teng et al.   BMJ Open

The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus

(2018) Tineke Kraaij et al.   JOURNAL OF AUTOIMMUNITY

Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study

(2017) Caiyun You et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren’s syndrome

(2016) Nicolyn Thompson et al.   RHEUMATOLOGY

Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis

(2014) Stephanie Glaesener et al.   Arthritis & Rheumatology

Prevalence and Clinical Significance of Anti–Laminin 332 Autoantibodies Detected by a Novel Enzyme-Linked Immunosorbent Assay in Mucous Membrane Pemphigoid

(2013) Philippe Bernard et al.   JAMA Dermatology

Combination of Rituximab and Intravenous Immunoglobulin for Recalcitrant Ocular Cicatricial Pemphigoid

(2010) C. Stephen Foster et al.   OPHTHALMOLOGY

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus

(2008) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM